Scientific Research and IP

While conducting a routine experiment, a researcher noticed an unexpected result that did not align with the original objective. Out of curiosity, they investigated the phenomenon further and discovered a new, useful property. This accidental observation became the foundation of a new invention.

“Now I’ll patent this and become a millionaire!” they thought excitedly.

In research-driven organizations, there is often a persistent belief that strong science naturally leads to strong intellectual property (IP) rights. Discovering a new material, a promising formulation, an elegant synthesis route, or an unexpected technical effect can feel like the most difficult part of the invention process. Once the experimental results have been collected and analyzed, patenting the invention may appear to be a straightforward process: document the invention, draft a patent application, and obtain a strong patent. In practice, however, the relationship between cutting-edge research and commercially valuable IP is far less direct.

This is because scientific research and patents are designed for different purposes. The goal of scientific research is to generate reliable new knowledge, answer questions, and create understanding about phenomena in the universe. Patents, by contrast, are tools for protecting new technical inventions by granting the patent holder a time-limited right to exclude others from commercially exploiting the invention in exchange for public disclosure of the invention. This fundamental distinction is particularly evident in the fields of engineering and natural sciences, where the first published result may be scientifically impressive yet commercially narrow and difficult to exploit in the market.

As a result, some universities and research organizations maintain patent portfolios that appear stronger on paper than they are in practice. A filed patent application or a granted patent may create the impression of technological maturity, but for a potential licensee, investor, or partner, the critical question is whether the IP genuinely supports a business decision. Is the invention described broadly enough? Is the technical advantage clear and credible? Can the patent support commercial collaboration, investment, product development, or a future exit scenario? If the answers are uncertain, the mere existence of IP may not reduce risk in the expected way, it may simply postpone these issues until later.

What turns research into strong IP?

If excellent scientific research does not automatically produce excellent IP, how can strong IP be created?

The answer usually lies in how the invention is developed from the very beginning. Strong patents rarely arise from scientific novelty alone. They are typically shaped by broader factors: collaboration with industry, active participation by inventors, effective organizational support, and a realistic understanding of where and how the invention could create value in the market.

This interpretation of the invention is often where the real work begins. Academic research emphasizes precision, novelty, and publishability within a limited experimental framework. Companies, on the other hand, focus on whether the invention can be expanded, reproduced, strategically protected, and commercially differentiated from alternative solutions. Can the invention extend beyond the initial experiment? Is the advantage tied to something reproducible? Does the patent retain strategic value beyond the original research? Are there realistic alternatives, fallback positions, or nearby implementations with commercial relevance?

Research-driven environments often lack a proper understanding of patent strategy because too much attention is placed solely on whether the invention is sufficiently novel to justify filing a patent application. This perspective overlooks how disclosure of the invention affects later use and commercialization. A more important question is whether the invention has been described and documented in a way that supports future use cases and enables broader applications.

In practice, this may mean identifying the true invention behind the first successful experimental result. Sometimes the value of a patent lies in covering a broader concept, such as a formulation, a structural or material relationship, or a manufacturing process, rather than a single isolated result. This makes the patent more flexible and expands its potential applications. It is also important to understand that the real value of a patent is determined by how effectively it supports licensing negotiations, startup financing, and collaboration agreements. The best patents do not emerge merely from legal drafting; they are built on careful technical judgment and a clear understanding of how value and utility are created after the application is filed. In this way, a patent can function as a genuinely strategic tool that supports commercialization and reduces future uncertainty.

What does this mean for companies, startups, and research organizations?

Companies should evaluate scientific inventions more carefully than simply by looking at the scope of patent protection. What matters is understanding the substance of the patent, the practical applicability of the invention, the required further development, and the technical rationale necessary for implementation. Patents should therefore be viewed as part of the innovation and commercialization process, not merely as achievements on paper.

For startups, the implications are significant. Founders coming from academic backgrounds often assume that owning or licensing a patent is enough to convince investors or create strategic advantage. Sometimes this is true, but more often the key issue is whether the patent supports a credible story about market position, defensibility, and future development opportunities. Investors and partners usually look far beyond the filing date or the wording of the claims. They value consistency, scalability, and realistic value creation. They want to understand whether the IP portfolio as a whole is coherent, scalable, and aligned with a credible path to commercial value. A strong IP portfolio reduces uncertainty, clarifies ownership, and supports negotiations and growth.

For universities and research organizations, this message may be the most important of all. The goal should not merely be increasing the number of patents but improving the quality and usability of IP generated from research. Patents are part of a broader impact strategy that includes collaboration, inventor engagement, and commercial readiness. Excellent research needs an IP strategy that supports the transfer of innovation from the laboratory to the market, allowing patents to become genuine strategic assets.

Practical ways to improve IP quality

1. Identify the real invention early
   Many patents remain too narrow because they are based directly on the first experiment or publication. From a quality perspective, the essential question is: what is truly new and inventive here? Instead of a single compound, for example, the real invention may involve a broader formulation or a process for producing compounds. This often requires technical discussion between the inventor and the patent professional before drafting the application.
   
2. Connect patenting to a real use case
   Good IP is not only technically novel and inventive; it is also linked to a credible use scenario. In universities, this means considering potential users already during the filing stage. In startups, it means aligning patents with the chosen market and development direction rather than seeking only “general protection.”
   
3. Invest in active inventor participation
   High-quality patents rarely emerge without genuine inventor involvement. A properly completed invention disclosure form alone is not enough. In the best cases, inventors participate in defining the claims, identifying alternative embodiments, and articulating the technical advantages. This improves both the logic of the protection scope and the patent’s future defensibility.
   
4. Build patents for future use, not just for grant
   Many weak patents are difficult to commercialize. It is worth evaluating whether the patent supports licensing, financing, partnerships, or freedom to operate. If the answer is unclear, the patent structure may need adjustment; for example, alternative claim categories and commercially meaningful dependent claims can be decisive.
   
5. For universities: quality before quantity
   The number of patents alone is not a good metric. A better approach is to focus on inventions with genuine commercial potential, collaborate with industry, and patent strategically at the right time.
   
6. For startups: make IP part of the story, not a standalone shield
   Investors are rarely interested in a patent alone. They care about how the IP supports competitive advantage, scalability, and future opportunities. High-quality IP is reflected in a patent portfolio that supports a clear strategic narrative: why this team, this technology, and this market.

Conclusion

The quality of IP originating from scientific research improves when patenting is viewed as part of innovation development and commercialization from the very beginning. This shift in mindset is often more important than individual legal decisions.

References and further reading

• European Patent Office – The role of European universities in patenting and innovation
• WIPO – Harnessing Public Research for Innovation in the 21st Century